» Articles » PMID: 33586450

Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies

Overview
Journal Circulation
Date 2021 Feb 15
PMID 33586450
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The relationship between dietary sodium intake and blood pressure (BP) has been tested in clinical trials and nonexperimental human studies, indicating a direct association. The exact shape of the dose-response relationship has been difficult to assess in clinical trials because of the lack of random-effects dose-response statistical models that can include 2-arm comparisons.

Methods: After performing a comprehensive literature search for experimental studies that investigated the BP effects of changes in dietary sodium intake, we conducted a dose-response meta-analysis using the new 1-stage cubic spline mixed-effects model. We included trials with at least 4 weeks of follow-up; 24-hour urinary sodium excretion measurements; sodium manipulation through dietary change or supplementation, or both; and measurements of systolic and diastolic BP at the beginning and end of treatment.

Results: We identified 85 eligible trials with sodium intake ranging from 0.4 to 7.6 g/d and follow-up from 4 weeks to 36 months. The trials were conducted in participants with hypertension (n=65), without hypertension (n=11), or a combination (n=9). Overall, the pooled data were compatible with an approximately linear relationship between achieved sodium intake and mean systolic as well as diastolic BP, with no indication of a flattening of the curve at either the lowest or highest levels of sodium exposure. Results were similar for participants with or without hypertension, but the former group showed a steeper decrease in BP after sodium reduction. Intervention duration (≥12 weeks versus 4 to 11 weeks), type of study design (parallel or crossover), use of antihypertensive medication, and participants' sex had little influence on the BP effects of sodium reduction. Additional analyses based on the BP effect of difference in sodium exposure between study arms at the end of the trial confirmed the results on the basis of achieved sodium intake.

Conclusions: In this dose-response analysis of sodium reduction in clinical trials, we identified an approximately linear relationship between sodium intake and reduction in both systolic and diastolic BP across the entire range of dietary sodium exposure. Although this occurred independently of baseline BP, the effect of sodium reduction on level of BP was more pronounced in participants with a higher BP level.

Citing Articles

Adipokine isthmin-1 is a potential predictor of abnormal urine Na excretion and insulin resistance for primary hypertension.

Deng C, Zhou X, Zhang L, You Q, Liu C, Zhang Y BMC Cardiovasc Disord. 2025; 25(1):136.

PMID: 40011820 PMC: 11863623. DOI: 10.1186/s12872-025-04585-z.


Analysis of Cardiovascular High-Risk Profile in Middle-Aged Lithuanian Men with Arterial Hypertension from 2009 to 2019.

Sileikiene V, Dzenkeviciute V, cypiene A, Slapikas T, Puronaite R, Badariene J Biomedicines. 2025; 13(2).

PMID: 40002686 PMC: 11852000. DOI: 10.3390/biomedicines13020272.


The association between urine-estimated salt intake and hypertension: findings of a population-based study.

Bahadoran Z, Mirmiran P, Ghasemi A, Azizi F Clin Hypertens. 2025; 31:e4.

PMID: 39944940 PMC: 11800285. DOI: 10.5646/ch.2025.31.e4.


Sodium Reduction Legislation and Urinary Sodium and Blood Pressure in South Africa.

Gaziano T, Kapaon D, du Toit J, Crowther N, Wade A, Fabian J JAMA Cardiol. 2025; .

PMID: 39908059 PMC: 11800126. DOI: 10.1001/jamacardio.2024.5410.


"Minimal-Advice" on Salt Intake: Results of a Multicentre Pilot Randomised Controlled Trial on Hypertensive Patients.

DElia L, Strazzullo P, Del Giudice A, Desideri G, Di Quattro R, Ferri C High Blood Press Cardiovasc Prev. 2025; 32(2):181-190.

PMID: 39883400 PMC: 11890317. DOI: 10.1007/s40292-025-00704-1.


References
1.
Ames R . The effect of sodium supplementation on glucose tolerance and insulin concentrations in patients with hypertension and diabetes mellitus. Am J Hypertens. 2001; 14(7 Pt 1):653-9. DOI: 10.1016/s0895-7061(01)01310-3. View

2.
Meland E, Laerum E, AAKVAAG A, Ulvik R, Hostmark A . Salt restriction: effects on lipids and insulin production in hypertensive patients. Scand J Clin Lab Invest. 1997; 57(6):501-5. DOI: 10.3109/00365519709084600. View

3.
. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention.... Arch Intern Med. 1997; 157(6):657-67. View

4.
Turck D, Castenmiller J, de Henauw S, Hirsch-Ernst K, Kearney J, Knutsen H . Dietary reference values for sodium. EFSA J. 2020; 17(9):e05778. PMC: 7009309. DOI: 10.2903/j.efsa.2019.5778. View

5.
Hwang J, Chin H, Kim S, Kim D, Kim S, Park J . Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial. Clin J Am Soc Nephrol. 2014; 9(12):2059-69. PMC: 4255393. DOI: 10.2215/CJN.01310214. View